Visualising treatment effects in low-vision settings: proven and potential endpoints for clinical trials of inherited retinal disease therapies. [PDF]
Thirunavukarasu AJ +2 more
europepmc +1 more source
Gene therapy trial lights the way for patients with Leber congenital amaurosis 1. [PDF]
Chan YK.
europepmc +1 more source
Safety of Adeno-Associated Viral Vectors in Gene Therapy: Mechanisms of Toxicity, Clinical Risks, and Strategies for Their Minimization. [PDF]
Tsaregorodtseva TS +6 more
europepmc +1 more source
The origins of Novo Nordisk and Novartis products: piloting a framework to identify the public contributions. [PDF]
Fabian D, Sehic O, Wild C.
europepmc +1 more source
A hierarchical and configurational analysis of Health Technology Assessment outcomes for cell and gene therapies. [PDF]
Almalki ZS +10 more
europepmc +1 more source
Disparities in access to gene therapy in the European Union: ethical and regulatory challenges. [PDF]
Reckelbus M +5 more
europepmc +1 more source
Streamlined synthetic regulatory cassette for efficient and photoreceptor-enriched retinal gene expression. [PDF]
Kwon JE +11 more
europepmc +1 more source
Should patients with pre-existing anti-AAV antibodies be excluded from receiving intrathecally delivered AAV vectors? [PDF]
Gray SJ.
europepmc +1 more source
Single-cell and spatial transcriptomic analyses of gene therapy-associated retinal inflammation in non-human primates. [PDF]
Sourd C +12 more
europepmc +1 more source
Advances and Challenges in Gene Therapy for Inherited Retinal Dystrophies: A Comprehensive Review. [PDF]
Jain R, Daigavane S.
europepmc +1 more source

